1064TiP - Phase I/II trial of tisotumab vedotin plus bevacizumab, pembrolizumab, or carboplatin in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8)
| Autor: | Vergote, I.B., Concin, N., Mirza, M.R., Malmberg, A., Eaton, L., Nicacio, L., Lorusso, D., Soumaoro, I., Monk, B.J., O’Malley, D.M. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v433-v434 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|